MedTrace Logo

Immunological Effects From Intranasal Chitin Micro-Particles

NCT01508039 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2012-01-26

No results posted yet for this study

Summary

The purpose of the study is:

* To investigate whether chitin can effect healthy adults, the nasal mucosa in a direction that will enhance the immune response to infection
* To investigate whether chitin influence of the nasal mucosa is well tolerated, and that there is no inflammation, as it seen with exposure to endotoxin.

Conditions

  • Healthy

Interventions

OTHER

Chitin Micro Particle

The total spray volume for each application is 0.4 ml equivalent to a total single-dose for chitin of 2 mg (0.5 mg per 0.1 ml spray). A total single-dose for LPS, of 2 mg of endotoxin from Enterobacter agglomerans (0.5 mg per 0.1 ml spray)

Sponsors & Collaborators

  • CMP Therapeutics Ltd

    collaborator INDUSTRY

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Torben Sigsgaard, Professor · Aarhus University, School of Public Health, Dept of Environmental & Occupational Medicine

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2011-06-30
Completion
2011-07-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01508039 on ClinicalTrials.gov